Cellectis (CLLS) Reports Q2 Loss of EUR0.23/Share
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Cellectis (NASDAQ: CLLS) reported Q2 EPS of (EUR0.23), versus (EUR0.43) reported last year. Revenue for the quarter came in at EUR18.14 million, versus EUR8 million reported last year.
For earnings history and earnings-related data on Cellectis (CLLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agree Realty (ADC) Tops Q3 FFO by 4c
- NBT Bancorp (NBTB) Reports Q3 EPS of $0.46
- Auburn National Bancorp (AUBN) Reports Q3 EPS of $0.54
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!